Voloridge Investment Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,545
Closed -$568K 1877
2021
Q2
$568K Buy
+5,545
New +$557K ﹤0.01% 1407
2021
Q1
Sell
-9,593
Closed -$740K 1680
2020
Q4
$740K Sell
9,593
-33,708
-78% -$2.61M 0.01% 1051
2020
Q3
$3.19M Sell
43,301
-11,482
-21% -$921K 0.03% 572
2020
Q2
$4.02M Buy
+54,783
New +$4.3M 0.05% 408
2020
Q1
Sell
-7,217
Closed -$567K 1420
2019
Q4
$567K Sell
7,217
-15,036
-68% -$1.11M 0.01% 791
2019
Q3
$1.52M Buy
+22,253
New +$1.49M 0.03% 531
2019
Q2
Sell
-9,782
Closed -$820K 1092
2019
Q1
$820K Buy
+9,782
New +$1.02M 0.02% 542
2018
Q4
Sell
-26,718
Closed -$3.22M 493
2018
Q3
$3.22M Buy
+26,718
New +$3.32M 0.07% 176

Other funds holding USNA

Voloridge Investment Management's USNA Position: Q3 2021 in Review

Voloridge Investment Management sold out of Usana Health Sciences (USNA) in Q3 2021, closing a stake of 5,545 shares — an estimated $568K sold.

Voloridge Investment Management first reported a position in USNA in Q3 2018 and held it in 8 quarters. The position peaked at $4.02M in Q2 2020. 180 funds tracked by Wall St. Rank hold USNA as of Q3 2021.

  • Voloridge Investment Management reported no remaining Usana Health Sciences position as of Q3 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 5,545 Usana Health Sciences shares in Q3 2021, an estimated $568K.
  • Voloridge Investment Management first reported a position in Usana Health Sciences in Q3 2018 and held it in 8 quarters.
  • Voloridge Investment Management's Usana Health Sciences position peaked at $4.02M in Q2 2020.
  • 180 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2021.

Based on Voloridge Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.